Local paclitaxel induces late lumen enlargement in coronary arteries after balloon angioplasty

[1] Smith SC(2006)American College of Cardiology/American Heart Association Task Force on Practice Guidelines; ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention) J Am Co

[2] Feldman TE(2010)Guidelines on myocardial revascularization Eur Heart J 31 2501-2555

[3] Hirshfeld JW(2003)Evidence for use of coronary stents. A hierarchical bayesian meta-analysis Ann Intern Med 138 777-786

[4] Wijns W(2004)Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty Am Heart J 147 815-822

[5] Kolh P(1984)Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute Am J Cardiol 53 77C-81C

[6] Danchin N(2012)Inhibition of neointimal hyperplasia with a novel zotarolimus coated balloon catheter Clin Res Cardiol 101 469-476

[7] Brophy JM(2012)Inhibition of neointimal proliferation after bare metal stent implantation with low-pressure drug delivery using a paclitaxel-coated balloon in porcine coronary arteries Clin Res Cardiol 101 385-391

[8] Belisle P(2006)Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter N Engl J Med 355 2113-2124

[9] Joseph L(2009)Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis Circulation 119 2986-2994

[10] Al Suwaidi J(2013)Drug-coated balloons in treatment of in-stent restenosis: a meta-analysis of randomised controlled trials Clin Res Cardiol 102 279-287

[1] Smith SC(2006)American College of Cardiology/American Heart Association Task Force on Practice Guidelines; ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention) J Am Co

[2] Feldman TE(2010)Guidelines on myocardial revascularization Eur Heart J 31 2501-2555

[3] Hirshfeld JW(2003)Evidence for use of coronary stents. A hierarchical bayesian meta-analysis Ann Intern Med 138 777-786

[4] Wijns W(2004)Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty Am Heart J 147 815-822

[5] Kolh P(1984)Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute Am J Cardiol 53 77C-81C

[6] Danchin N(2012)Inhibition of neointimal hyperplasia with a novel zotarolimus coated balloon catheter Clin Res Cardiol 101 469-476

[7] Brophy JM(2012)Inhibition of neointimal proliferation after bare metal stent implantation with low-pressure drug delivery using a paclitaxel-coated balloon in porcine coronary arteries Clin Res Cardiol 101 385-391

[8] Belisle P(2006)Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter N Engl J Med 355 2113-2124

[9] Joseph L(2009)Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis Circulation 119 2986-2994

[10] Al Suwaidi J(2013)Drug-coated balloons in treatment of in-stent restenosis: a meta-analysis of randomised controlled trials Clin Res Cardiol 102 279-287